表紙
市場調查報告書
商品編碼
858354

乳癌的診斷、治療設備

Breast Cancer Diagnostic and Treatment Devices

出版日期: | 出版商: Datamonitor Healthcare | 英文 134 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球乳癌診斷、治療設備市場相關調查,乳癌和其亞型的流行病學的概要,各成像、活體組織切片 (切片檢查) 、治療市場區隔的產品分析,產業的主要企業、新興企業的競爭分析,市場成長的推動要素、阻礙因素相關考察等彙整資料。

摘要整理

第1章 乳癌概要

  • 風險因素
  • 檢測、診斷
    • 臨床性乳房檢驗
    • 篩檢乳房X光攝影
    • 其他乳癌成像技術
    • 活體組織切片
    • 樣品試驗
  • 治療途徑
    • 手術
    • 切除治療
    • 化療
    • 放射線治療
    • 荷爾蒙療法
    • 標靶治療
  • 參考資料

第2章 乳癌的成像、活體組織切片產品

  • 乳房X光攝影以及其他成像產品
    • 底片式乳房X射線攝影系統
    • 電腦X光攝影系統
    • FFDM系統
    • 數位乳房斷層攝影系統
    • CAD軟體
    • 乳腺超音波自動檢驗系統 (ABUS)
    • 乳房專用MRI線圈
    • CT
  • 定位切片檢查引導系統
  • 微創活體組織切片產品
    • 核心針切片檢查系統
    • VAB系統
  • 乳癌成像、活體組織切片產品市場
    • 全球市場的考察
    • 市場規模
    • 市場區隔的考察
    • 地區的考察
    • 市場趨勢
    • 促進市場成長要素與阻礙因素
    • 市場領導
  • 參考資料

第3章 乳癌的治療設備

  • 乳癌手術
    • 腫瘤切除引導系統
  • 乳房照射
    • EBRT
    • 加速乳房部分照射 (APBI)
    • 乳房照射3D細胞標記
  • 乳癌的微創切除
    • 冷凍切除
    • 雷射組織內高溫度治療
  • 部分乳房照射、切除治療產品市場
    • 市場規模
    • 市場區隔的考察
    • 地區的考察
    • 市場趨勢
    • 促進市場成長要素與阻礙因素
    • 市場領導
  • 參考資料

附錄:企業清單

目錄
Product Code: #MDT18020

Overview

This analysis includes a discussion of competitors, markets (current and future), products, and opportunities in the global market for breast cancer diagnostic and treatment devices.

The report provides the following useful information:

  • an epidemiological overview of breast cancer and its subtypes
  • product analysis by imaging, biopsy, and treatment segment
  • competitive analysis of industry leaders and emerging competitors
  • insight into factors driving and limiting market growth estimated market forecasts.

TABLE OF CONTENTS

Executive Summary

  • i. Breast cancer overview
  • ii. Global breast cancer market
    • a. Market drivers and limiters
    • b. Breast cancer imaging, biopsy, and tissue-sparing treatments overview
    • c. Technology trends
    • d. Market leaders
    • e. Competitive strategies
    • f. Emerging competition
  • iii Methodology
  • Exhibit ES-1: Breast imaging and biopsy products, global market forecast ($m), 2017-22
  • Exhibit ES-2: Partial breast irradiation and ablation treatments for breast cancer, global market forecast ($m), 2017-22

1. Breast Cancer Overview

  • 1.1 Risk factors
  • 1.2 Detection and diagnosis
    • 1.2.1 Clinical breast exam
    • 1.2.2 Screening mammography
      • 1.2.2.1 Limitations of screening mammography
      • 1.2.2.2 National screening programs
      • 1.2.2.3 Overdiagnosis controversies
      • 1.2.2.4 Personalized breast screening
      • 1.2.2.5 Types of mammography system
      • 1.2.2.6 Installed base of mammography systems
    • 1.2.3 Other breast cancer imaging technologies
      • 1.2.3.1 Breast MRI
      • 1.2.3.2 Automated breast ultrasound
      • 1.2.3.3 Molecular breast imaging
      • 1.2.3.4 Positron emission mammography
      • 1.2.3.5 Tomographic optical breast imaging
      • 1.2.3.6 Radiofrequency imaging
    • 1.2.4 Biopsy
    • 1.2.5 Sample testing
      • 1.2.5.1 Gene expression profiling
      • 1.2.5.2 Protein expression profiling (IHC)
  • 1.3 Treatment pathways
    • 1.3.1 Surgery
    • 1.3.2 Ablative therapies
    • 1.3.3 Chemotherapy
    • 1.3.4 Radiation therapy
    • 1.3.5 Hormone therapy
    • 1.3.6 Targeted treatments
  • 1.4 Bibliography
  • Exhibit 1-1: Estimated incident cases of breast cancer by molecular subtype, US, 2017 and 2022
  • Exhibit 1-2: Estimated incident cases of breast cancer by molecular subtype, 5EU, 2017 and 2022
  • Exhibit 1-3: Estimated incident cases of breast cancer by molecular subtype, Japan, 2017 and 2022
  • Exhibit 1-4: Estimated incident cases of breast cancer by stage, US, 2017 and 2022
  • Exhibit 1-5: Estimated incident cases of breast cancer by stage, 5EU, 2017 and 2022
  • Exhibit 1-6: Estimated incident cases of breast cancer by stage, Japan, 2017 and 2022
  • Exhibit 1-7: Factors that increase the relative risk for breast cancer in women
  • Exhibit 1-8: National screening guidelines for breast cancer and possible changes (in bold)
  • Exhibit 1-9: Developments in breast screening technology
  • Exhibit 1-10: Installed base of mammography systems in the US, Japan, and 5EU

2. Breast Cancer Imaging and Biopsy Products

  • 2.1 Mammography and other imaging products
    • 2.1.1 Film-based mammography systems
    • 2.1.2 Computed radiography systems
    • 2.1.3 FFDM systems
    • 2.1.4 Digital breast tomosynthesis systems
      • 2.1.4.1 Fujifilm
      • 2.1.4.2 GE Healthcare
      • 2.1.4.3 General Medical Merate
      • 2.1.4.4 Hologic
      • 2.1.4.5 Planmed Oy
      • 2.1.4.6 Siemens Healthineers
    • 2.1.5 CAD software
      • 2.1.5.1 Selected commercial CAD systems
      • 2.1.5.2 Future developments
    • 2.1.6 Automated breast ultrasound systems
    • 2.1.7 Breast-specific MRI coils
    • 2.1.8 Computed tomography
  • 2.2 Stereotactic biopsy guidance systems
  • 2.3 Minimally invasive biopsy products
    • 2.3.1 Core-needle biopsy systems
    • 2.3.2 VAB systems
  • 2.4 Breast cancer imaging and biopsy products market
    • 2.4.1 Global market insights
    • 2.4.2 Market value
    • 2.4.3 Segment insights
      • 2.4.3.1 Mammography
      • 2.4.3.2 ABUS
      • 2.4.3.3 MRI coils
      • 2.4.3.4 Biopsy systems
    • 2.4.4 Regional insights
      • 2.4.4.1 Market forecast: US
      • 2.4.4.2 Market forecast: Five major EU markets
      • 2.4.4.3 Market forecast: Japan
      • 2.4.4.4 Market forecast: Rest of the world
    • 2.4.5 Market trends
    • 2.4.6 Market drivers and limiters
    • 2.4.7 Market leaders
      • 2.4.7.1 Hologic
      • 2.4.7.2 GE Healthcare
      • 2.4.7.3 Siemens Healthineers
      • 2.4.7.4 Other major players
  • 2.5 Bibliography
  • Exhibit 2-1: Selected FFDM systems
  • Exhibit 2-2: Selected ongoing trials comparing synthetic mammography/DBT to FFDM
  • Exhibit 2-3: Selected digital breast tomography (DBT) systems
  • Exhibit 2-4: Selected commercially available ABUS systems
  • Exhibit 2-5: Selected stereotactic biopsy guidance systems and tables
  • Exhibit 2-6: Breast imaging and biopsy products, combined market forecast, by product segment ($m), 2017-22
  • Exhibit 2-7: Mammography systems, combined market forecast, by product segment ($m), 2017-22
  • Exhibit 2-8: ABUS systems, global market forecast ($m), 2017-22
  • Exhibit 2-9: Global MRI coil sales, market forecast ($m), 2017-22
  • Exhibit 2-10: Biopsy systems, global market forecast ($m), 2017-22
  • Exhibit 2-11: Breast imaging and biopsy products, US market forecast ($m), 2017-22
  • Exhibit 2-12: Breast imaging and biopsy products, 5EU market forecast ($m), 2017-22
  • Exhibit 2-13: Breast imaging and biopsy products, Japan market forecast ($m), 2017-22
  • Exhibit 2-14: Breast imaging and biopsy products, RoW market forecast ($m), 2017-22
  • Exhibit 2-15: Breast imaging and biopsy systems market, share by supplier, 2017

3. Breast Cancer Treatment Devices

  • 3.1 Breast cancer surgery
    • 3.1.1 Lumpectomy guidance systems
  • 3.2 Breast irradiation
    • 3.2.1 EBRT
    • 3.2.2 Accelerated partial breast irradiation
      • 3.2.2.1 EBRT for APBI
      • 3.2.2.2 High-dose rate brachytherapy
      • 3.2.2.3 Image-guided radiation therapy
      • 3.2.2.4 IORT
      • 3.2.2.5 Stereotactic radiotherapy
      • 3.2.2.6 Current recommendations for the use of APBI
    • 3.2.3 3D tissue marker for breast irradiation
  • 3.3 Minimally invasive ablation of breast cancer
    • 3.3.1 Cryoablation
      • 3.3.1.1 Products under development
    • 3.3.2 Laser interstitial thermotherapy
  • 3.4 Partial breast irradiation and ablation treatments products market
    • 3.4.1 Market value
    • 3.4.2 Partial breast irradiation and ablation systems - segment insights
    • 3.4.3 Regional insights
    • 3.4.4 Trends in the partial breast irradiation and ablation systems market
      • 3.4.4.1 Mergers and acquisitions
      • 3.4.4.2 Reimbursement trends
      • 3.4.4.3 Treatment trends
      • 3.4.4.4 Technology trends
    • 3.4.5 Market drivers and limiters
    • 3.4.6 Market leaders
  • 3.5 Bibliography
  • Exhibit 3-1: Lumpectomy, procedure volumes forecast, selected countries/regions, 2017-22
  • Exhibit 3-2: Selected APBI systems
  • Exhibit 3-3: Partial breast irradiation and ablation product sales, combined market forecast, by product segment ($m), 2017-22
  • Exhibit 3-4: Global partial breast irradiation and ablation systems sales and share by country/region, 2017
  • Exhibit 3-5: APBI systems market, share by supplier, 2017

Appendix: Company Listing